• <em>STRN-ALK</em> rearranged malignant peritoneal mesothelioma-Presenting with bilateral extensive pelvic masses in a young woman: Mimicking low-grade serous ovarian carcinoma
• A 47-year-old man with rare serous cyst adenocarcinoma of the testis
• A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma
• A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment
• A rare case of ductal variant multilocular prostatic cystadenocarcinoma invading the rectum
• A rare case of high-grade intraductal carcinoma of the upper lip: immunohistochemical and genetic analyses
• A Rare Distant Metastasis of Papillary Cystadenocarcinoma Arising from Maxillary Gingiva
• Advanced Ovarian Cancer during Pregnancy. Tumour Evolution Analysis and Treatment Approach
• Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?
• Ancestry-specific predisposing germline variants in cancer
• APOBEC3C is a novel target for the immune treatment of lower-grade gliomas
• Appendageal tumors and tumor-like lesions of the testis and paratestis: a 32-year experience at a single institution
• Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
• Assessment of oncological safety and utility of hysteroscopy in high grade endometrial cancers: Results from an Israel gynecologic oncology group study
• Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types
• CD137+ tumor infiltrating lymphocytes predicts ovarian cancer survival
• Chronic expanding hematoma in the liver: a case report
• Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type
• Comprehensive analysis of the novel omicron receptor AXL in cancers
• Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint
• Cystic biliary tumors of the liver: diagnostic criteria and common pitfalls
• Cystic liver neoplams: A single centre experience and literature review
• Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma
• Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary
• Differentiating benign from malignant pancreatic cysts on computed tomography
• Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis
• Elevated OGN expression correlates with the EMT signature and poor prognosis in ovarian carcinoma
• Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytologic Evaluation of Intraductal Papillary Mucinous Neoplasm and Mucinous Cystic Neoplasms of Pancreas
• Evaluation of the Potential Diagnostic Utility of the Determination of Selected Caspases-Markers Involved in the Regulation of Apoptosis-In Patients with Ovarian Cancer
• Factor affecting lymph node metastasis in uterine papillary serous carcinomas: a retrospective analysis
• Hepatic Cysts: Reappraisal of the Classification, Terminology, Differential Diagnosis, and Clinicopathologic Characteristics in 258 Cases
• Hepatobiliary mucinous cystic neoplasms and mimics
• HER2-positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature
• High <em>HOXA9</em> gene expression predicts response to chemotherapy and prognosis of high-grade serous ovarian cancer patients
• Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers
• Identifying the worst of the worst: HER2 positive early stage uterine papillary serous carcinoma
• Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis
• KRAS-mutated Uterine Endometrioid Carcinoma With Extensive Surface Changes Resulting in Striking Morphologic Mimicry of an Ovarian Serous Borderline Tumor
• Liquid biopsy in the detection of tumor relapse in primary peritoneal serous papillary carcinoma
• Low-Grade Intraductal Carcinoma of the Parotid Gland: A Case Report and Literature Review
• Low-grade serous ovarian cancer: expert consensus report on the state of the science
• Metastatic Neoplasms Involving the Stomach
• Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report
• Mixed primary mucinous cystadenocarcinoma and invasive ductal carcinoma of the breast: a case report and literature review
• Molecular genetic changes in solid pseudopapillary neoplasms (SPN) of the pancreas
• Morphologic and Immunocytochemical Features of High-Grade Serous Carcinoma of Ovary in Ascitic Fluid Effusion and Fine-Needle Aspiration Cytology
• MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor
• Mucinous cystadenocarcinoma of breast in a 69-year-old woman with positive hormone receptors, the first case reported
• Mucinous Cystadenocarcinoma of the Pancreas with Cyst Infection in a Male Patient
• Mucinous cystic neoplasm of the liver (MCN-L): a rare presentation and review of the literature
• Multimodality Imaging Approach to Ovarian Neoplasms with Pathologic Correlation
• Neoplastic lesions in domestic pigs detected at slaughter: literature review and a 20-year review (1998-2018) of carcass inspection in Catalonia
• NFAT Overexpression Correlates with CA72-4 and Poor Prognosis of Ovarian Clear-Cell Carcinoma Subtype
• Non-Neoplastic and Neoplastic Cysts of the Pancreas
• Novel therapeutics in low-grade serous ovarian cancer
• Nuclear morphometry as an adjunct to cytopathologic examination of endometrial brushings on LBC samples: A prospective approach to combined evaluation in endometrial neoplasms and look alikes
• Outcomes of surgical resection for pulmonary metastasis from ovarian cancer
• Ovarian Mesonephric-like Adenocarcinoma With Multifocal Microscopic Involvement of the Fimbrial Surface: Potential for Misdiagnosis of Tubal Intraepithelial Metastasis as Serous Tubal Intraepithelial Carcinoma Associated With Ovarian High-grade Serous Car
• Ovarian Serous Carcinoma With a Novel HSP90AB1 Mutation in a Patient With Synchronous Primary Fallopian Tube Serous Carcinoma
• Pancreatic Intraductal Papillary Mucinous Neoplasm-Derived Cancer, Mucinous Cystic Neoplasm-Derived Cancer, and Adenocarcinoma: National Survival Outcomes
• Papillary cystadenocarcinoma of the parotid gland: a rare sub-variant of salivary gland adenocarcinoma
• Papillary lesions of the breast
• Papillary Neoplasms of the Salivary Duct System: A Review
• Pathologic primary tumor factors associated with risk of lymph node involvement in patients with non-endometrioid endometrial cancer
• PAX8 plays an essential antiapoptotic role in uterine serous papillary cancer
• PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer
• Primary mucinous cystadenocarcinoma of the breast: a clinicopathologic analysis of one case and review of the literature
• Primary Mucinous Cystadenocarcinoma of the Breast: Clinicopathological Analysis of a Case and Difficulties Encountered in a Biopsy
• Primary peritoneal low-grade serous carcinoma detected in cervical smear: Pitfalls mitigated by clinicocytopathologic clues and cellblock immunocytochemistry
• Primary Retroperitoneal Mucinous Cystadenocarcinoma: A Case Report
• Primary retroperitoneal serous adenocarcinoma: A case report of rare malignancy with literature review
• Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer
• Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study
• Prominent Papillary Growth Pattern and Severe Nuclear Pleomorphism Induced by Neoadjuvant Chemotherapy in Ovarian Mucinous Carcinoma: Potential for Misdiagnosis as High-grade Serous Carcinoma
• Rewired functional regulatory networks among miRNA isoforms (isomiRs) from let-7 and miR-10 gene families in cancer
• Role of Cross-sectional Imaging (CT/MRI) in Characterization and Distinguishing Benign from Malignant/Potentially Malignant Cystic Lesions of Pancreas
• Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors
• Salivary gland cystadenocarcinoma: Rare neoplasm in buccal mucosa
• Salivary Mucinous Adenocarcinoma Is a Histologically Diverse Single Entity With Recurrent AKT1 E17K Mutations: Clinicopathologic and Molecular Characterization With Proposal for a Unified Classification
• Serous surface papillary borderline ovarian tumors: correlation of sonographic features with clinic pathological findings
• Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues
• SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens
• Spectrum of Mesenchymal-Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis
• Subtyping of high grade serous ovarian carcinoma: histopathological and immunohistochemical approach
• Successful Surgical Management of Giant Mucinous Cystic Neoplasm of Liver (MCN-L) Presenting With Peritoneal Rupture and Biliary Prolapse: Case Report and Review of Literature
• Surveillance and management for serous cystic neoplasms of the pancreas based on total hazards-a multi-center retrospective study from China
• Survival outcomes and prognostic factors of papillary serous adenocarcinoma and papillary squamous cell carcinoma of the uterine cervix
• The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor
• The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes
• The molecular feature of macrophages in tumor immune microenvironment of glioma patients
• The Spectrum of Mucinous Lesions of the Breast
• Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis
• Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States
• TXNDC17 protein overexpression in uterine papillary serous carcinoma is associated with clinicopathological characteristics and prognosis
• Updated WHO classification of tumors of the breast: the most important changes
• Uterine choriocarcinoma arising from serous carcinoma in a postmenopausal woman: an analysis of next-generation sequencing and PD-L1 immunochemistry
• Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts
• Well-Differentiated Papillary Mesothelioma with Omental Calcifications: A Case Report and Review of the Literature
• Well-Differentiated Papillary Mesothelioma With Two Synchronous Serous Gynaecologic Carcinomas in a 62-Year-Old Woman: Lessons Learned for the Gynaecologic Surgeon
• Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome